Gary P. Sims

机构：AstraZeneca (Brazil), AstraZeneca (Finland), AstraZeneca (Spain) · ORCID：0000-0003-2796-0485

发表论文 67 篇 · 总被引 6931 次 · h-index 29

代表论文

• Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus (2018 · Lupus Science & Medicine · 被引 150)
• S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo (2015 · PLoS ONE · 被引 128)
• Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils (2017 · Frontiers in Immunology · 被引 122)
• Evidence for a direct link between PAD4-mediated citrullination and the oxidative burst in human neutrophils (2018 · Scientific Reports · 被引 108)
• Oxidised IL-33 drives COPD epithelial pathogenesisviaST2-independent RAGE/EGFR signalling complex (2023 · European Respiratory Journal · 被引 91)
• Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal (2020 · Science Advances · 被引 74)